New Zealand Pharmaceuticals Ltd:企業の戦略的SWOT分析

◆英語タイトル:New Zealand Pharmaceuticals Ltd - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY2865
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ニュージーランド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

New Zealand Pharmaceuticals Ltd – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

New Zealand Pharmaceuticals Ltd (NZP) a subsidiary of Archer Capital, manufactures and supplies pharmaceutical intermediates and diagnostic products for pharmaceutical and microbiological media companies. It also offers biochemicals and natural extracts for health, cosmetic, biotechnology, food, and aquaculture industries. The company’s products include dietary supplements, carbohydrates, microbiological and cell culture media, pharmaceutical intermediates and ingredients, feed ingredients, excipients and blackcurrant extract. NZP uses various technologies such as enzyme and chemical hydrolyses; large scale aqueous and organic solvent extractions; ion-exchange purification, distillation, ultrafiltration, filtration and centrifugation; crystallisation, milling and chemical synthesis; and spray drying to manufacture its products. NZP is headquartered in Palmerston North, New Zealand.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
New Zealand Pharmaceuticals Ltd – Key Facts
New Zealand Pharmaceuticals Ltd – Key Employees
New Zealand Pharmaceuticals Ltd – Key Employee Biographies
New Zealand Pharmaceuticals Ltd – Key Operational Employees
New Zealand Pharmaceuticals Ltd – Major Products and Services
New Zealand Pharmaceuticals Ltd – History
New Zealand Pharmaceuticals Ltd – Company Statement
New Zealand Pharmaceuticals Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
New Zealand Pharmaceuticals Ltd – Business Description
New Zealand Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
New Zealand Pharmaceuticals Ltd – Strengths
New Zealand Pharmaceuticals Ltd – Weaknesses
New Zealand Pharmaceuticals Ltd – Opportunities
New Zealand Pharmaceuticals Ltd – Threats
New Zealand Pharmaceuticals Ltd – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
New Zealand Pharmaceuticals Ltd, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
New Zealand Pharmaceuticals Ltd, Key Facts
New Zealand Pharmaceuticals Ltd, Key Employees
New Zealand Pharmaceuticals Ltd, Key Employee Biographies
New Zealand Pharmaceuticals Ltd, Key Operational Employees
New Zealand Pharmaceuticals Ltd, Major Products and Services
New Zealand Pharmaceuticals Ltd, History
New Zealand Pharmaceuticals Ltd, Subsidiaries
New Zealand Pharmaceuticals Ltd, Joint Venture
New Zealand Pharmaceuticals Ltd, Key Competitors
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
New Zealand Pharmaceuticals Ltd, Recent Deals Summary

List of Figures
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[New Zealand Pharmaceuticals Ltd:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dollar Tree Inc:戦略・SWOT・企業財務分析
    Dollar Tree Inc - Strategy, SWOT and Corporate Finance Report Summary Dollar Tree Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • BW Offshore Ltd (BWO):石油・ガス:M&Aディール及び事業提携情報
    Summary BW Offshore Ltd (BW Offshore) is a floating production services provider to the oil and gas industry. The company specializes in the design, development, and operation of oil and gas Floating Production, Storage and Offloading (FPSO) and Floating, Storage and Offloading (FSO) vessels. It off …
  • DURECT Corp (DRRX)-医療機器分野:企業M&A・提携分析
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …
  • Young’s Market Co LLC:企業の戦略的SWOT分析
    Young's Market Co LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Kiewit Corp:企業の戦略的SWOT分析
    Kiewit Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ford Motor Company:戦略・SWOT・企業財務分析
    Ford Motor Company - Strategy, SWOT and Corporate Finance Report Summary Ford Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Williams Partners LP:企業のM&A・事業提携・投資動向
    Williams Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Williams Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Warba Insurance Company – K.S.C.P:企業の戦略・SWOT・財務情報
    Warba Insurance Company - K.S.C.P - Strategy, SWOT and Corporate Finance Report Summary Warba Insurance Company - K.S.C.P - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Nippon Express Co Ltd:企業の戦略・SWOT・財務分析
    Nippon Express Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nippon Express Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Olympus America Inc:医療機器:M&Aディール及び事業提携情報
    Summary Olympus America Inc (Olympus America), a subsidiary of Olympus Corporation is medical device company that designs, develops and manufactures medical and surgical products, industrial measurement and imaging instruments, life science imaging systems, and cameras and audio products. The compan …
  • Exelixis Inc (EXEL):製薬・医療:M&Aディール及び事業提携情報
    Summary Exelixis Inc (Exelixis) is a biopharmaceutical company that focuses on the development and commercialization of small molecule therapies for the treatment of cancer. The company has three product candidates: Cometriq (Cabozantinib), an inhibitor of multiple receptor tyrosine kinases; Cabomet …
  • LIncoln Electric Holdings Inc:企業のM&A・事業提携・投資動向
    LIncoln Electric Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LIncoln Electric Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Brodrene Hartmann A/S:企業の戦略・SWOT・財務情報
    Brodrene Hartmann A/S - Strategy, SWOT and Corporate Finance Report Summary Brodrene Hartmann A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Itausa – Investimentos Itau S.A.:企業の戦略・SWOT・財務情報
    Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report Summary Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Medicamen Biotech Ltd (531146):企業の財務・戦略的SWOT分析
    Medicamen Biotech Ltd (531146) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • California Institute for Biomedical Research:製薬・医療:M&Aディール及び事業提携情報
    Summary California Institute for Biomedical Research (Calibr) is a not for profit organization that offers translational research. The organization discovers and develops therapies for unmet medical needs. It conducts research in the human disease areas of degenerative and age-related diseases, canc …
  • Advanced Biological Laboratories SA-医療機器分野:企業M&A・提携分析
    Summary Advanced Biological Laboratories SA (ABL) is a healthcare information technology company that provides integrated software solutions for personalised medicine. The company’s products include improving disease management software, project management software, cumulative reporting and related …
  • Transplant Genomics Inc:企業の製品パイプライン分析2018
    Summary Transplant Genomics Inc (TGI) is a biotech company. The company carries out performing organ transplantation using non-invasive serial monitoring under the guidance of genomics. It aims in detecting early signs of graft injury by conducting molecular diagnostic tests, enabling in differentia …
  • Franchise Services of North America Inc:戦略・SWOT・企業財務分析
    Franchise Services of North America Inc - Strategy, SWOT and Corporate Finance Report Summary Franchise Services of North America Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Michels Corp:企業の戦略・SWOT・財務情報
    Michels Corp - Strategy, SWOT and Corporate Finance Report Summary Michels Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆